← FDA Drug Approvals (Drugs@FDA)
DIFLUNISAL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HERITAGE PHARMA · Approved 2012-03-08
Drug application
- FDA Application #
ANDA202845- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIFLUNISAL
- Generic name
- DIFLUNISAL
- Active ingredients
- DIFLUNISAL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HERITAGE PHARMA
- Manufacturer
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- First approval
- 2012-03-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown